Agency News
'Why buy a network that even Dentsu couldn’t fix?': Inside the gamble of Dentsu's international arm sale
Piramal Pharma has awarded its integrated media mandate to OMD India, part of Omnicom Media Group. Following a multi-round pitch, the agency has been selected to handle the mandate of scaling the brand through sharp, creative and forward-leaning communication efforts.
OMD India will spearhead the strategic marketing and media efforts for Piramal Pharma’s portfolio of OTC brands, including Lacto Calamine, Little’s, Tetmosol, Polycrol, and Women’s intimate health range like i-pill and i-activ, and will be managed out of the agency’s Mumbai office.
“We are excited to embark on this partnership with Piramal Consumer Healthcare, a company that mirrors our commitment to innovation and excellence,” said Anisha Iyer, CEO of OMD India.
She added, “This collaboration presents a significant opportunity to leverage our strategic acumen and deep market intelligence to elevate Piramal's impressive portfolio of brands to new heights. Together, we aim to craft media strategies that go beyond visibility—building lasting trust and loyalty with consumers across India and shaping a future of sustained growth and impact.”
Today’s B2B marketers wear many hats: strategist, technologist, and storyteller.
Read MoreThe GCC's expansion is not limited to GIFT City. These centres are also accelerating in tier-2 locations such as Bhubaneshwar, Coimbatore, Kochi, and Chandigarh, where promising talent pools are attracting interest